No Data
No Data
Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?
Viking Therapeutics Options Spot-On: On April 29th, 53,329 Contracts Were Traded, With 176.65K Open Interest
Viking Among Notable Gainers as Pfizer Raises Deal Prospects
Cantor Fitzgerald Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Cuts Target Price to $104
Truist Financial Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Announces Target Price $75
New Analyst Forecast: $VKTX Given 'Overweight' Rating